Search research articles
Contact Us
Filters
Showing results (91-100 of 282) with videos related to
Page
of 29
Sort By:
Antiviral Therapy
|
December 3, 2008
Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation
Marta Boffito, Laura Else, David Back, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2009
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
Laura Dickinson, Marta Boffito, David Back, et al.
Antimicrobial Agents and Chemotherapy
|
June 29, 2011
Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation
Marta Boffito, Akil Jackson, Alieu Amara, et al.
HIV Clinical Trials
|
December 1, 2017
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals
Akil Jackson, Laura Else, Christopher Higgs, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2025
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens
Laura Dickinson, Laura Else, Willem D F Venter, et al.
The Journal of Antimicrobial Chemotherapy
|
February 7, 2021
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine
Aida N Kawuma, Stephen I Walimbwa, Goonaseelan Colin Pillai, et al.
Thorax
|
June 5, 2010
Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease
, Heather Milburn, Neil Ashman, et al.
AIDS Reviews
|
February 10, 2017
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women
Saye Khoo, Gilles Peytavin, David Burger, et al.
The Journal of Antimicrobial Chemotherapy
|
October 9, 2009
Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets
Louisa Pollock, Laura Else, Goenke Poerksen, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2020
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
Daryl Hodge, Fiona Marra, Catia Marzolini, et al.
Page
of 29
Search research articles
Search
Showing results (91-100 of 282) with videos related to
Sort By:
Page
of 29
Antiviral Therapy
|
December 3, 2008
Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation
Marta Boffito, Laura Else, David Back, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2009
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
Laura Dickinson, Marta Boffito, David Back, et al.
Antimicrobial Agents and Chemotherapy
|
June 29, 2011
Pharmacokinetics of once-daily darunavir-ritonavir and atazanavir-ritonavir over 72 hours following drug cessation
Marta Boffito, Akil Jackson, Alieu Amara, et al.
HIV Clinical Trials
|
December 1, 2017
Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals
Akil Jackson, Laura Else, Christopher Higgs, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2025
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens
Laura Dickinson, Laura Else, Willem D F Venter, et al.
The Journal of Antimicrobial Chemotherapy
|
February 7, 2021
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine
Aida N Kawuma, Stephen I Walimbwa, Goonaseelan Colin Pillai, et al.
Thorax
|
June 5, 2010
Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease
, Heather Milburn, Neil Ashman, et al.
AIDS Reviews
|
February 10, 2017
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women
Saye Khoo, Gilles Peytavin, David Burger, et al.
The Journal of Antimicrobial Chemotherapy
|
October 9, 2009
Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets
Louisa Pollock, Laura Else, Goenke Poerksen, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2020
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies
Daryl Hodge, Fiona Marra, Catia Marzolini, et al.
Page
of 29